メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
Search content at Keio University
ホーム
プロファイル
研究部門
研究成果
医学部
慶應義塾大学
学部
概要
フィンガープリント
ネットワーク
プロファイル
(446)
研究成果
(25114)
フィンガープリント
医学部が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Neoplasm
100%
Surgery
54%
Disease
54%
Malignant Neoplasm
46%
Computer Assisted Tomography
36%
Recurrent Disease
35%
Overall Survival
35%
Symptom
27%
Odds Ratio
25%
Retrospective Study
24%
Hazard Ratio
24%
Esophageal Cancer
23%
COVID-19
23%
Magnetic Resonance Imaging
23%
Hepatocellular Carcinoma
23%
Adverse Event
22%
Metastatic Carcinoma
21%
Lung Cancer
20%
Stomach Cancer
19%
Cohort Analysis
19%
Survival Rate
19%
Percutaneous Aortic Valve Replacement
18%
Quality of Life
18%
Bleeding
18%
Diagnosis
18%
Esophagectomy
17%
Systematic Review
17%
Dry Eye
17%
Observational Study
17%
Prevalence
17%
Percutaneous Coronary Intervention
17%
Injury
17%
Surgeon
16%
Endoscopic Submucosal Dissection
16%
Biological Marker
16%
Prognostic Factor
16%
Infection
15%
Clinical Trial
15%
Meta-Analysis
15%
Randomized Controlled Trial
15%
Clear Cell Renal Cell Carcinoma
14%
Apoplexy
14%
Heart Failure
14%
Hepatectomy
14%
Colorectal Cancer
14%
Body Mass Index
14%
Prostate Cancer
14%
Retrospective Cohort Study
14%
Multivariate Analysis
14%
Endometrial Cancer
14%
Lymph Node Metastasis
13%
Cardiovascular System
13%
Ulcerative Colitis
13%
Transitional Cell Carcinoma
13%
Stem Cell
12%
Medicine
12%
Cross Sectional Study
12%
Adenocarcinoma
12%
Postoperative Complication
12%
Cardiovascular Disease
12%
Rheumatoid Arthritis
12%
Radiation Therapy
12%
Non Small Cell Lung Cancer
12%
Logistic Regression Analysis
11%
Spinal Cord Injury
11%
Pediatrics
11%
Diabetes
11%
In Vitro
11%
Esophageal Squamous Cell Carcinoma
11%
Recurrence Free Survival
11%
Elderly Patient
11%
Cancer Cell
11%
Drug Therapy
11%
Breast Cancer
11%
Ossification
11%
Atrial Fibrillation
10%
Induced Pluripotent Stem Cell
10%
Cancer
10%
Combination Therapy
10%
Progression Free Survival
10%
Cervical Cancer
10%
Biopsy
10%
Pancreas Cancer
10%
Cancer Surgery
10%
Cell Transplantation
9%
T Cell
9%
Mortality Rate
9%
Liver Transplantation
9%
Retroperitoneal Lymph Node Dissection
9%
Neoadjuvant Chemotherapy
9%
Endothelial Cell
9%
Gastrectomy
9%
Surgical Technique
8%
Visual Acuity
8%
Ovarian Cancer
8%
Posterior Longitudinal Ligament
8%
Clinical Feature
8%
Cisplatin
8%
Hospital Mortality
8%
Adolescent Idiopathic Scoliosis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
53%
Neoplasm
48%
Mouse
46%
Malignant Neoplasm
40%
Chemotherapy
27%
Adverse Event
26%
Overall Survival
24%
Cohort Study
24%
Recurrent Disease
20%
Symptom
20%
Rheumatoid Arthritis
19%
Remission
18%
Cardiovascular Disease
17%
Heart Failure
17%
Infection
16%
Clinical Trial
16%
Prevalence
15%
Biological Marker
15%
Inflammation
15%
Cisplatin
13%
Liver Cell Carcinoma
13%
Stomach Cancer
13%
Combination Therapy
13%
Pharmacokinetics
12%
Lung Cancer
12%
Antipsychotic
12%
Observational Study
12%
Randomized Controlled Trial
12%
Retrospective Study
12%
Receptor
11%
Renal Cell Carcinoma
11%
Ulcerative Colitis
11%
Cytokine
11%
Survival Rate
11%
Progression Free Survival
11%
Prostate Cancer
10%
Coronavirinae
10%
Injury
10%
Chronic Kidney Failure
10%
Non Small Cell Lung Cancer
9%
Atrial Fibrillation
9%
Diabetes Mellitus
9%
Mouse Model
9%
Non Insulin Dependent Diabetes Mellitus
9%
Colorectal Cancer
9%
Esophagus Cancer
8%
Monotherapy
8%
Epidermal Growth Factor Receptor
8%
Tumor Necrosis Factor
8%
Placebo
8%
Dry Eye
8%
Syndrome
8%
Typical Antipsychotic
8%
Diseases
8%
Crohn's Disease
8%
Helicobacter Pylori
7%
Pulmonary Hypertension
7%
Bleeding
7%
Chemoradiation Therapy
7%
C Reactive Protein
7%
Cross-Sectional Study
7%
Pancreas Cancer
7%
Disease Activity
7%
Fluorouracil
6%
Sepsis
6%
Inflammatory Bowel Disease
6%
Clinical Study
6%
Transitional Cell Carcinoma
6%
Methotrexate
6%
Recurrence Free Survival
6%
Heart Infarction
6%
Endometrium Cancer
6%
Breast Cancer
6%
Castration Resistant Prostate Cancer
6%
Vaccination Policy
6%
Docetaxel
6%
Ischemia
6%
Spinal Cord Injury
6%
Esophageal Squamous Cell Carcinoma
6%
Clinical Feature
6%
Vasculotropin
6%
Normal Human
5%
Angiotensin II
5%
Side Effect
5%
Paclitaxel
5%
Tocilizumab
5%
Hospital Mortality
5%
Prospective Cohort Study
5%
Hearing Impairment
5%
Ovary Cancer
5%
Nivolumab
5%
Hemodialysis
5%
Pharmacotherapy
5%
Mortality Rate
5%
Adenocarcinoma
5%
Interleukin 6
5%
Glucocorticoid
5%
Chronic Obstructive Lung Disease
5%
Renin
5%
Prospective Study
5%
Keyphrases
Japan
59%
Confidence Interval
23%
Tumor
13%
Japanese Patients
13%
Overall Survival
13%
Clinical Outcomes
12%
Hazard Ratio
11%
Risk Factors
11%
Rheumatoid Arthritis
9%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
9%
Odds Ratio
9%
Esophageal Cancer
8%
Induced Pluripotent Stem Cells (iPSCs)
8%
Ulcerative Colitis
8%
Meta-analysis
8%
Hepatocellular Carcinoma
7%
Retrospective Cohort Study
7%
Chemotherapy
6%
COVID-19
6%
Dry Eye
6%
Clinical Practice Guidelines
6%
Japanese Population
6%
Neural Stem Cells
6%
Endoscopic Submucosal Dissection
6%
Surgical Outcomes
6%
Endometrial Cancer
5%
Colorectal Cancer
5%
After Surgery
5%
Cardiovascular Disease
5%
Adverse Events
5%
Spinal Cord Injury
5%
Systematic Meta-analysis
5%
Graft-versus-host Disease (GvHD)
5%
Esophageal Squamous Cell Carcinoma
5%
Transplantation
5%
Multicenter Cohort Study
5%
Gastric Cancer
5%
No Significant Difference
5%